Market & News

To, The Shareholders, M/s Asarfi Hospital Limited

Your Directors have the pleasure in presenting the 20th Annual Report on the business operations of the Company for the financial year ended on March 31, 2025 together with the Audited Financial Accounts and Auditor's Report thereon for the financial year 2024 – 25:

1. FINANCIAL STATEMENT:

The financial performance of the Company for the financial year ended on March 31, 2025 is summarized below -

	STANDALONE		CONSOLIDATED
Particulars	31st March 2025	31st March 2024	31st March 2025	31st March 2024
	(In Lakh)	(In Lakh)	(In Lakh)	(In Lakh)
Revenue from Operations	12,056.57	8,440.04	12,056.57	8,440.04
Other Income	756.90	167.01	751.99	167.01
Total Income	12,813.47	8,607.05	12,808.56	8,607.05
Profit before Interest, Tax and Depreciation	3,141.29	1,778.12	3,106.80	1,773.56
Less: Financial Cost	408.09	270.69	408.09	270.69
Less: Depreciation	1,261.74	878.25	1,267.60	878.75
Profit before Tax	1,471.46	629.18	1,431.11	624.12
Less: Current Tax	307.56	-	307.56	-
Less: Deferred Tax Assets/ (Liability)	65.46	190.56	65.46	190.56
Less: Prior Period Taxes	0.46	17.40	0.46	17.40
Profit after Tax	1,097.97	421.22	1,057.62	416.16
Profit Bought Forward	421.22	801.53	416.16	801.53
Balance carried to Balance Sheet	1,519.19	1,222.75	1,473.79	1,217.69

2. DESCRIPTION OF THE COMPANY'S OPERATIONS / STATE OF AFFAIRS DURING THE YEAR:

During the year, on the basis of Standalone Financials, the Company has generated revenue from operations of Rs. 1205657494.00/- (including other income) and earned net profit after tax Rs. 109797279.00/- as compared with the corresponding figures in the previous year of Rs. 844003553.00/- and Rs. 42122026.00/- respectively. The total revenue is increased by Rs. 361653941.00/- as compared with last year as well as net profit after tax also increased by Rs. 67675253.00/- as compared with last year. During the year, on the basis of Consolidated Financials, the Company has generated revenue from operations of Rs. 1205657494.00/- (including other income) and earned net profit after tax Rs. 105762388.00/-.

3. DIVIDEND:

Your directors have not recommended any dividend for the current financial year.

4. TRANSFER TO RESERVE:

The Board of Directors of your company has decided to transfer Rs. 109797279.00/- to the Reserves for the year under review.

5. DETAILS OF SUBSIDIARIES, ASSOCIATES AND JOINT VENTURES:

During the year, the Company has one wholly owned subsidiary "Asarfi Educational Foundation". There are no Associates and Joint Venture Companies.

6. LISTING WITH THE STOCK EXCHANGE(S):

The Equity Shares of the Company are presently listed on BSE (SME Platform) Limited and the Company has paid the applicable listing fees to the Stock Exchange till date.

7. DETAILS RELATING TO DEPOSITS, COVERED UNDER CHAPTER V OF THE COMPANIES ACT 2013

The Company has not accepted any public deposits and as such, no amount on account of principal or interest on public deposits was outstanding as on the date of the balance sheet.

8. DETAILS OF DIRECTORS AND KEY MANAGERIAL PERSONNEL:

BOARD OF DIRECTORS: During the year under review, the following directors are acting on the Board of the Company:

. Particulars	DIN	Designation
01 Udai Pratap Singh	08453794	Managing Director
02 Sukanti Kumar Das	01842846	Non-Executive Director
03 Madhuri Singh	06562038	Executive Director
04 Gopal Singh	01608342	Executive Director
05 Amit Kumar Barnwal	09039421	Independent Director
06 Rajkumari Sharma	09538512	Independent Director

KEY MANAGERIAL PERSONNEL: In terms of Section 203 of the Companies Act, 2013, the following are the Key Managerial Personnel of the Company:

Particulars	Designation
01 Harendra Singh	Chief Financial Officer Company Secretary & Compliance
02 Sudipa Singh	Officer
03 Udai Pratap Singh	Managing Director

9. APPOINTMENT/ RE- APPOINTMENT AND RESIGNATION OF DIRECTORS/ KEY MANAGERIAL PERSONNEL (KMP):

During the FY 24-25, On September 30, 2024, Seepika Gupta (Mem No: A37984) resigned from the post of Company Secretary cum Compliance Officer. Further, on December 24, 2024, Mrs. Vandana Bhojgaria (Mem No: A62117) was appointed for the post of Company Secretary cum Compliance Officer. Further, on March 03rd, Mrs. Vandana Bhojgaria (Mem No: A62117) resigned from the post of Company Secretary & Compliance Officer. Further, on June 03rd, 2025 Mrs. Sudipa Singh (Mem No: A56989) was appointed for the post of Company Secretary cum Compliance Officer of the Company.

10. BOARD MEETINGS:

During the year, nine (9) meetings of the Board of Directors were held, details of which are given below:

Sl. No.	Date of Meeting
01	06/05/2024
02	19/06/2024
03	20/08/2024
04	13/09/2024
05	07/10/2024
06	30/10/2024
07	24/12/2024
08	31/01/2025
09	28/03/2025

11. GENERAL MEETINGs

During the year, one (1) meetings of the Members were held, details of which are given below:

Sl. No.	Date of Meeting
01	13/09/2024

12. CORPORATE GOVERNANCE:

As per the Guideline and direction of the SEBI & Stock Exchange accordingly the company has been adhering to the directions and guideline, as required and if applicable on the Companies size and type (as per the Regulations and rules the Corporate Governance is not applicable on SME Listed Companies). Certificate on Non- Applicability of the Corporate Governance Report is set out as Annexure "Certificate on Non- Applicability of the Corporate Governance Report on page 120" to this Report.

13. EXTRACT OF ANNUAL RETURN

The Extract of Annual Return as provided under Section 92(3) of the Companies Act, 2013 and as prescribed in Form No. MGT- 9 of the Companies (Management and Administration) Rules, 2014 is appended as ANNEXURE "Form No. Mgt-9 Extract of Annual Return as on The Financial Year Ended On 31.3.2025.on page 81"to this Report.

14. COMMITTEES OF THE BOARD:

There are currently three Committees of the Board, as follows: I. Audit Committee

II. Stakeholders' Relationship Committee III. Nomination and Remuneration Committee IV. Risk Management Committee V. Corporate Social Responsibility Committee

I. AUDIT COMMITTEE

Committee Constitution is as follows:

Name	Position in the Committee	Designation
Amit Kumar Barnwal	Chairman	Independent Director
Rajkumari Sharma	Member	Independent Director
Udai Pratap Singh	Member	Managing Director

Such constitution of the Audit Committee meets the requirements of Section 177 of the Companies Act, 2013 and Regulation 18 of the Listing Obligations & Disclosure Requirements Regulations, 2015. Company Secretary and Compliance Officer of our Company would act as the Secretary to the Audit Committee. During the year, seven (7) meetings of the Audit Committee Members were held, details of which are given below:

Sl. No.	Date of Meeting
01	06/05/2024
02	19/06/2024
03	20/08/2024
04	13/09/2024
05	07/10/2024
06	30/10/2024
07	31/01/2025

II. Stakeholders' Relationship Committee

Committee Constitution is as follows:

Name	Position in the Committee	Designation
Amit Kumar Barnwal	Chairman	Non-Executive Director
Rajkumari Sharma	Member	Independent Director
Udai Pratap Singh	Member	Managing Director

During the year, three (3) meetings of the Stakeholder Committee Members were held, details of which are given below:

Sl. No.	Date of Meeting
01	19/06/2024
02	07/10/2024
03	28/03/2025

III. Nomination and Remuneration Committee

Committee Constitution is as follows:

Name	Position in the Committee	Designation
Amit Kumar Barnwal	Chairman	Independent Director
Rajkumari Sharma	Member	Independent Director Non-Executive
Sukanti Kumar Das	Member	Director

Such constitution of the Nomination & Remuneration Committee meets the requirements of Section 178 of the Companies Act, 2013 and Regulation 19 of the Listing Obligations & Disclosure Requirements Regulations, 2015.

During the year, four (4) meetings of the Nomination & Remuneration Committee Members were held, details of which are given below:

Sl. No.	Date of Meeting
01	06/05/2024
02	20/08/2024
03	13/09/2024
04	24/12/2024

IV. Risk Management Committee

Committee Constitution is as follows:

Name	Position in the Committee	Designation
Amit Kumar Barnwal	Chairman	Independent Director
Rajkumari Sharma	Member	Independent Director
Sukanti Kumar Das	Member	Non-Executive Director

During the year, two (2) meetings of the Risk Management Committee Members were held, details of which are given below:

Sl. No.	Date of Meeting
01	24/12/2024
02	28/03/2025

V. Corporate Social Responsibility Committee

Committee Constitution is as follows:

Name	Position in the Committee	Designation
Amit Kumar Barnwal	Chairman	Independent Director
Rajkumari Sharma	Member	Independent Director
Udai Pratap Singh	Member	Managing Director

During the year, three (3) meetings of the Corporate Social Responsibility Committee Members were held, details of which are given below:

Sl. No.	Date of Meeting
01	06/05/2024
02	20/08/2024
03	28/03/2025

15. FAMILIARIZATION PROGRAMME FOR INDEPENDENT

DIRECTORS:

The Company has practice of conducting familiarization Programme for Independent Directors of the Company. Every new independent director of the Board attended an orientation program. To familiarize the new inductees with the strategy, operations and functions of our Company, the executive directors/senior managerial personnel make presentations to the inductees about the Company's strategy, operations, product and service offerings, markets, software delivery, organization structure, finance, human resources, technology, quality, facilities and risk management.

The Company has organized the following workshops for the benefit of Directors and Independent Directors: a) a program on how to review, verify and study the financial reports; b) Provisions under the Companies Act, 2013;and c) SEBI Insider Trading Regulation, 2015. Further, at the time of appointment of an independent director, the Company issues a formal letter of appointment outlining his/her role, functions, duties and responsibilities as a director.

16. DECLARATION BY INDEPENDENT DIRECTORS

The Independent Directors of your Company have submitted the declaration of Independence as required under Section 149(7) of the Companies Act, 2013 confirming that they meet the criteria of independence under Section 149(6) of the Companies Act, 2013. Moreover, the necessary declaration from each of the Independent Directors of the Company as required under Section 149(7) of the Companies Act, 2013 is enclosed as ANNEXURE "Declaration of Independence on page 116".

17. SIGNIFICANT AND MATERIAL ORDERS PASSED BY

THE REGULATORS OR COURTS OR TRIBUNALS:

During the year under review, no significant and material orders were passed by the Regulators or Courts or Tribunals having an impact on the going concern status and future operations of the Company.

18. MATERIAL CHANGES AND COMMITMENTS, IF ANY,

AFFECTING THE FINANCIAL POSITION OF THE COMPANY WHICH HAVE OCCURRED BETWEEN THE END OF THE FINANCIAL YEAR OF THE COMPANY TO WHICH THE FINANCIAL STATEMENTS RELATE AND THE DATE OF THE REPORT:

During the year under review the following material changes were occurred: a. During the year, on May 19, 2025, Asarfi Hospital Limited in Dhanbad has formed a strategic partnership with Gleneagles Hospital, Chennai. This collaboration, formalized through a Memorandum of Understanding (MoU) will establish the state's first multi-organ transplant unit in Dhanbad. b. Further, no other material changes and commitment have been made, which affect the financial position of the company occurred between the end of the financial year of the company to which the financial statements relate and the date of the report.

19. MANAGEMENT DISCUSSION AND ANALYSIS REPORT

As required under the Listing Regulation, Management Discussion and Analysis Report is presented in the separate section and forms an integral part of the Directors' Report as ANNEXURE "Management Discussion on page 35"

20. PARTICULARS OF LOANS, GUARANTEES, OR

INVESTMENTS

The details of Loans given, Investments made and guarantees given and securities provided under the Section 186 of the Companies Act, 2013 have been provided in the notes to the Financial Statements.

21. OBLIGATION OF COMPANY UNDER THE SEXUAL

HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION, PROHIBITION & REDRESSAL) ACT, 2013:

Your Company is committed to creating and maintaining an atmosphere in which employees can work together, without fear of sexual harassment, exploitation and intimidation. Accordingly, the Company has in place an Anti-Sexual Harassment Policy in line with the requirements of The Sexual Harassment of Women at the Workplace (Prevention, Prohibition & Redressal) Act 2013. Internal Complaints

Committee (ICC) was set up to redress complaints received regarding sexual harassment. All employees (Permanent, Contractual, temporary, trainees) are covered under this policy. The following is a summary of sexual harassment complaints received and disposed of during the year: No. of Complaints received.

No. of Complaints received.	Nil
No. of Complaints disposed off	Nil

22. CORPORATE SOCIAL RESPONSIBILITY:

In pursuant to the provisions of section 135 and schedule VII of the Companies Act, 2013, CSR Committee of the Board of Directors was formed to recommend (a) the policy on Corporate Social Responsibility (CSR) and (b) implementation of the CSR Projects or Programs to be undertaken by the Company as per CSR Policy for consideration and approval by the Board of Directors. The CSR policy framework is available on the Company's website at https://www.asarfi.in/investors/policies/pdf/CSR Policy.pdf The disclosures required to be given under Section 135 of the Companies Act, 2013 read with Rule 8(1) of the Companies (Corporate Social Responsibility Policy) Rules, 2014 are given in Annexure Annual Report on CSR activities on page 105" forming part of this Board Report.

23. AUDIT AND AUDITORS:

STATUTORY AUDITOR:

At the Nineteenth AGM held on September 13, 2024, the Members approved the appointment R.K. THAKKAR & CO., Chartered Accountants, Dhanbad (Firm Registration No. 002690C) as Statutory Auditors of the Company to hold office for a period of five years from the conclusion of that AGM till the conclusion of the twenty-third AGM to be held in the year 2028.

There is no qualification, reservation or adverse remark or disclaimer made in the Auditor's Report, needing explanations or comments by the Board. The Statutory Auditors have not reported any incident of fraud to the Audit Committee in the year under review against the Company by its officers or employees as specified under Section 143(12) of the Act SECRETARIAL AUDITOR: In compliance with Regulation 24A of the SEBI Listing Regulations and Section 204 of the Act, the Board at its meeting held on May 08th, 2025, based on recommendations of the Audit Committee, has approved the appointment of Ritu Ritolia & Co., Practising Company Secretaries, a peer reviewed firm (Firm Registration No. S2013JH203800) as Secretarial Auditors of the Company for a term of five consecutive years commencing from FY 2025-26 till FY 2029-30, subject to approval of the Members at the ensuing AGM.

COST AUDITOR:

During the period under review, Cost Audit is not applicable to the Company but the Company maintains the Cost Record. INTERNAL AUDITOR: During the period under review, D CHANCHANI & CO, CHARTERED ACCOUNTANTS, SRI RAM PLAZA BANK MORE, DHANBAD 826001 has been appointed as Internal Auditor of the Company in the Board Meeting held on May 06th, 2024.

24. CFO CERTIFICATION:

The Chief Executive Officer and Chief Financial Officer Certification as required under Regulation 17(8) read with Part B of Schedule II of the SEBI(LODR) Regulation, 2015 have been appended as ANNEXURE "Certificates on page 121" to this report.

25. BOARDS'S COMMENTS ON AUDITOR'S REPORTS:

There is no qualification, reservation or adverse remark made either by the Statutory Auditor or the Secretarial Auditor in his/ her report pertaining to the financial year under review.

26. REPORTING OF FRAUDS BY AUDITORS:

In terms of Section 143(12) of the Companies Act, 2013, neither the Statutory Auditor nor the Secretarial Auditor has found any instances of frauds in the Company during the course of performance of their duties as such. This clause is therefore not applicable on the Company.

27. DEVELOPMENT AND IMPLEMENTATION OF RISK

MANAGEMENT POLICY:

The Company has developed and implemented a risk management policy which identifies major risks which may threaten the existence of the Company. The same has also been adopted by your Board and is also subject to its review from time to time. Risk mitigation process and measures have been also formulated and clearly spelled out in the said policy.

28. CONSERVATION OF ENERGY, TECHNOLOGICAL

ABSORPTION AND FOREIGN EXCHANGE EARNINGS & OUTGO:

The management of your Company would like to share the highlights of its performance on the conservation of energy, technology absorption, foreign exchange earnings and outgo, as below:

• CONSERVATION OF ENERGY/ RESOURCES:

The Company is continuously striving towards improving the energy conservation measures in all areas. Company ensures strict compliance with all the statutory requirements and has taken several sustainable steps voluntarily to contribute towards better environment. Few steps are listed below: ? Conservation of natural resources like electricity, oil and fuel. ? Use of natural lighting and natural ventilation. ? Rainwater harvesting and water conservation; ? Reduce, reuse, recycle of waste and eco-friendly waste disposal.

• TECHNOLOGY ABSORBTION:

With the globally changing business environment, it is necessary to have developed technology. The Company has undertaken various initiatives towards technology absorption and derived benefits like cost reduction, product improvement and product development etc.

• FOREIGN EXCHANGE EARNINGS AND OUTGO:

The foreign exchange earnings and outgo during the financial year 2023-24 is Nil.

29. DIRECTOR'S RESPONSIBILITY STATEMENT:

Pursuant to the provision of section 134(5) of the Companies Act 2013, your Directors confirmed that: a. In the preparation of the Annual Accounts for the Financial year ended 31st March 2025, the applicable Accounting Standards have been followed and there is no material departure from the same; b. The directors had selected such accounting policies and applied them consistently and made judgment and estimates that are reasonable and prudent so as to give a true and fair view of the State of affairs of the company as of 31st March, 2025 and of the profit of the company for that period. c. The directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of Companies Act, 2013 for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities; d. The directors have prepared the annual accounts on a going concern basis. e. The directors have devised proper system to ensure compliance with the provision of all applicable laws and that such systems were adequate and operating effectively.

30. PARTICULARS OF LOANS, GUARANTEES OR

INVESTMENTS:

The details of Loans, Guarantees and Investments covered under the provisions of Section 186 of the Companies Act, 2013 are given in the notes to the Financial Statements.

31. PARTICULARS OF CONTRACTS OR ARRANGEMENTS

WITH RELATED PARTIES:

During FY 2023-24, Company has entered into some transactions with related parties as defined under Section 2(76) of the Companies Act, 2013, which were in the ordinary course of business and at arms' length basis. Further, the transactions were in accordance with the provisions of the Companies Act, 2013, read with rules framed thereunder and the SEBI (LODR) Regulations, 2015. The details of the related party transactions as required under applicable accounting standard are set out in Notes to the financial statements. The detail disclosure of these transactions in Form AOC- 2 pursuant to Section 134 (3) (h) of the Companies Act, 2013 read with Rule 8(2) of the Companies (Accounts) Rules, 2014 is set out as ANNEXURE "Form AOC – 2 on page 103" to this Report.

32. ADEQUACY OF INTERNAL FINANCIAL CONTROLS:

The management has put in place effective Internal Control Systems to provide reasonable assurance for: ? Safeguarding assets and their usage; ? Maintenance of Proper Accounting Records; ? Adequacy and Reliability of the information used for carrying on Business Operations. The Audit Committee as well as the Board of Directors reviews the adequacy and effectiveness of internal financial controls with respect to the financial statements and suggests improvement for strengthening them, from time to time.

33. PERFORMANCE EVALUATION:

The Board of Directors formulated and adopted a Board Evaluation Framework for the period under review for evaluating the performance of the Board as whole, as a committee and as individual directors. Pursuant to the said evaluation framework, the Board evaluated the performance its performance as well as of its committees and of individual directors for the Financial Year 2024–25 and consequent to such evaluation, it was of the view that the performance of the Board as a whole was adequate and fulfilled the parameters stipulated in the evaluation framework in its pro- growth activity and successfully faced challenging operational climatic and economic adversities during the year. Further the Individual Directors fulfilled their applicable responsibilities and duties laid down by the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the Companies Act, 2013 and at the same time contributed with their valuable knowledge, experience and expertise to grab the opportunity and counter the adverse challenges faced by the Company during the year.

34. VIGIL MECHANISM:

The Company has adopted a Whistle Blower Policy, as part of the Vigil Mechanism to provide appropriate avenues to the Directors and Employees of the Company to bring to the attention of the management any issue which is perceived to be in the violation of or in conflict with the business interest of the company. During the year, there have been no complaints received.

35. REMUNERATION OF DIRECTORS:

• NON- EXECUTIVE DIRECTORS: The Non- Executive Director shall be entitled to such sums as sitting fees as may be approved by the Board from time to time for all such meetings of the Board and/ or Committees as may be attended by them. Such sitting fees shall however be within the overall limits as prescribed under the

Companies Act, 2013 read with the Rules framed thereunder. Presently, no sitting fees have been prescribed by the Board of Directors.

• EXECUTIVE DIRECTORS: The Company shall pay remuneration by way of salaries, perquisites and allowances, fixed as well as variable to the Managing Director as well as Whole Time Directors. Such remuneration shall be subject to the provisions of Section 197 and other sections, if any, of the Companies Act, 2013 read with Schedule V of the Act. If in any financial year, the Company has no profits or inadequate profits, such remuneration shall be in accordance with the provisions of Schedule V of the Act and if not in compliance thereof, prior approval of the Central Government shall be requisite. The Key Managerial Personnel, Senior Managerial Personnel and other employees of the Company shall be paid monthly remuneration as per the Company's policy or as may be approved by the Nomination & Remuneration Committee. Disclosure under Section 197 of the Companies Act, 2013 is set out as ANNEXURE "Disclosure Under Section 197 of the Companies Act, 2013 on page 114" to this Report.

36. DETAILS OF APPLICATION MADE OR PROCEEDING

PENDING UNDER INSOLVENCY AND BANKRUPTCY CODE, 2016:

During the financial year under review, the Company has neither made any application, nor any application or proceeding are pending under the Insolvency and Bankruptcy Code, 2016.

37. CHANGES IN MEMORANDUM AND ARTICLE OF

ASSOCIATION

During the year, there is no change in Memorandum and Article of Association of the Company.

38. TRANSFER OF SHARES:

During the year, no transfer has been taken place.

39. WEBSITE

As per Regulation 46 of SEBI (Listing Obligations and Disclosure Requirements Regulations 2015, the Company has maintained a functional website namely " https://asarfi.in" containing basic information about the Company. The website of the Company is containing information like Policies, Shareholding Pattern, Financial and information of the designated officials of the Company who are responsible for assisting and handling investor grievances for the benefit of all stakeholders of the Company.

40. DETAILS OF APPLICATION MADE UNDER THE

INSOLVENCY AND BANKRUPTCY CODE, 2016

The company has not made any application or any proceeding pending under the Insolvency and Bankruptcy Code, 2016 during the year.

41. DETAILS OF DIFFERENCE BETWEEN THE AMOUNT OF

THE VALUATION DONE AT THE TIME OF ONE TIME SETTLEMENT AND THE VALUATION DONE WHILE TAKING LOAN FROM THE BANKS

There is no such event in the company.

42. ACKNOWLEDGEMENT:

Your Board wishes to place on record its deep appreciation of Directors of your company for their immense contribution by way of strategic guidance, sharing of knowledge, experience and wisdom, which help your company take right decisions in achieving its business goals.

Your Board acknowledges with thanks the support given by suppliers, customers, Bankers, Government Authorities, Shareholders and Employees of the Company at all levels and looks forward for their continued support.

	For and on behalf of the Board,
	ASARFI HOSPITAL LIMITED
	Sd/-	Sd/-
	UDAI PRATAP SINGH	MADHURI SINGH
DATE: 20.08.2025	Managing Director	Director
PLACE: Jharkhand	DIN: 08453794	DIN: 00484115